Please ensure Javascript is enabled for purposes of website accessibility

5 of Last Week's Biggest Losers

By Rick Munarriz – Nov 5, 2012 at 4:06AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

These stocks went the wrong way last week.

There's never a shortage of losers in the stock market.

Let's take a closer look at five of this past week's biggest sinkers.

Company

Nov. 2

Weekly Loss

My Watchlist

Active Network (ACTV)

$5.42

(40%)

Add

Western Union (WU 0.27%)

$11.95

(33%)

Add

Vringo (NYSEMKT: VRNG)

$2.77

(31%)

Add

Glu Mobile (GLUU)

$2.56

(21%)

Add

VIVUS (VVUS)

$14.33

(18%)

Add

Source: Barron's.

The Big Board's biggest sinker last week was Active Network. The leading provider of online registrations for marathons, triathlons, and other organized events was running the wrong way after a poorly received quarterly report.

Active Network's eyeing a larger-than-expected sequential dip in revenue for the fourth quarter, and targeting another net loss on top-line growth of 12% to 14% in 2013 was shy of what the market was expecting.

Western Union bounced like a bad check after the money-transfer giant offered up unimpressive guidance. Western Union is lowering prices in key markets in a move to combat competitive pressures, and that obviously won't help results in the near term.

Vringo stumbled after a judge moved to narrow the window of prior damages that the company can go after in its patent infringement suit against several dot-com bellwethers.

Several analysts moved to downgrade Glu Mobile on Friday after the app maker posted troublesome guidance. It sees a widening deficit for the period, expecting revenue to come in as much as 27% below Wall Street's top-line target.

VIVUS shed some weight after health-care research firm IMS Health reported that physicians have been writing far fewer prescriptions for VIVUS' anti-obesity drug, Qsymia, than Wall Street was expecting this quarter.

Longtime Fool contributor Rick Aristotle Munarriz has no positions in the stocks mentioned above. The Motley Fool owns shares of Western Union. Motley Fool newsletter services recommend The Active Network and Western Union. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.